Background Human African trypanosomiasis (HAT) is an infectious disease with a large global health burden occurring primarily in Central and Eastern Africa. Most current treatments have poor blood brain barrier (BBB) penetration, which prevent them from targeting the most lethal stage of the infection. In addition, current therapeutics suffer from a variety of limitations ranging from serious side effects to difficulties with treatment administration. Therefore it is of crucial importance to find new treatments that are safe, affordable, and effective against both sub-species of Trypanosoma brucei. Methods Semi-synthetic derivatization of the fungally-derived natural product merulin A (1) has led to the discovery of new development candidates for the protozoan parasite T. brucei, the causative agent of HAT. Creation of an initial SAR library based around the merulin scaffold revealed several key features required for activity, including the endoperoxide bridge, as well as one position suitable for further derivatization. Subsequent synthesis of a 20-membered analogue library, guided by the addition of acyl groups that improve the drug-like properties of the merulin A core, resulted in the development of compound 12 with an IC50 of 60 nM against T. brucei, and a selectivity index greater than 300-fold against HeLa and immortalized glial cells. Significance We report the semi-synthetic optimization of the merulin class of endoperoxide natural products as development candidates against T. brucei. We have identified compounds with low nM antiparasitic activities and high selectivity indices against HeLa cells. These compounds can be produced economically in large quantities via a one step derivatization from the microbial fermentation broth isolate, making them encouraging lead candidates for further development.
References
[1]
Schmid C, Nkunku S, Merolle A, Vounatsou P, Burri C (2004) Efficacy of 10-day melarsoprol schedule 2 years after treatment for late-stage gambiense sleeping sickness. Lancet 364: 789–790 doi:10.1016/S0140-6736(04)16940-7.
[2]
Pink R, Hudson A, Mouriès M-A, Bendig M (2005) Opportunities and challenges in antiparasitic drug discovery. Nat Rev Drug Discov 4: 727–740 doi:10.1038/nrd1824.
[3]
Jacobs RT, Nare B, Wring SA, Orr MD, Chen D, et al. (2011) SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis. PLoS Neglect Trop D 5: e1151 doi:10.1371/journal.pntd.0001151.
[4]
Torreele E, Bourdin Trunz B, Tweats D, Kaiser M, Brun R, et al. (2010) Fexinidazole–a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Neglect Trop D 4: e923 doi:10.1371/journal.pntd.0000923.
Kumar S, Gupta S, Singh P, Bajpai P, Gupta M, et al. (2004) High yields of artemisinin by multi-harvest of Artemisia annua crops. Ind Crop Prod 19: 77–90 doi:10.1016/j.indcrop.2003.07.003.
[7]
Rubio BK, Tenney K, Ang K-H, Abdulla M, Arkin M, et al. (2009) The marine sponge Diacarnus bismarckensis as a source of peroxiterpene inhibitors of Trypanosoma brucei, the causative agent of sleeping sickness. J Nat Prod 72: 218–222 doi:10.1021/np800711a.
[8]
Feng Y, Davis Ra, Sykes M, Avery VM, Camp D, et al. (2010) Antitrypanosomal cyclic polyketide peroxides from the Australian marine sponge Plakortis sp. J Nat Prod 73: 716–719 doi:10.1021/np900535z.
[9]
Holla H, Labaied M, Pham N, Jenkins ID, Stuart K, et al. (2011) Synthesis of antitrypanosomal 1,2-dioxane derivatives based on a natural product scaffold. Bioorg Med Chem Lett 21: 4793–4797 doi:10.1016/j.bmcl.2011.06.059.
[10]
Oguri H, Hiruma T, Yamagishi Y, Oikawa H, Ishiyama A, et al. (2011) Generation of Anti-trypanosomal Agents through Concise Synthesis and Structural Diversification of Sesquiterpene Analogues. J Am Chem Soc 133: 7096–7105 doi:10.1021/ja200374q.
[11]
Chokpaiboon S, Sommit D, Teerawatananond T, Muangsin N, Bunyapaiboonsri T, et al. (2010) Cytotoxic nor-chamigrane and chamigrane endoperoxides from a basidiomycetous fungus. J Nat Prod 73: 1005–1007 doi:10.1021/np100103j.
[12]
Liu D-Z, Dong Z-J, Wang F, Liu J-K (2010) Two novel norsesquiterpene peroxides from basidiomycete Steccherinum ochraceum. Tetrahedron Lett 51: 3152–3153 doi:10.1016/j.tetlet.2010.04.048.
[13]
Li H, Huang H, Shao C, Huang H, Jiang J, et al. (2011) Cytotoxic norsesquiterpene peroxides from the endophytic fungus Talaromyces flavus isolated from the mangrove plant Sonneratia apetala. J Nat Prod 74: 1230–1235 doi:10.1021/np200164k.
[14]
Chokpaiboon S, Sommit D, Bunyapaiboonsri T, Matsubara K, Pudhom K, et al. (2011) Antiangiogenic effect of chamigrane endoperoxides from a Thai mangrove-derived fungus. J Nat Prod 74: 2290–2294 doi:10.1021/np200491g.
[15]
O'Brien C, Henrich PP, Passi N, Fidock DA (2011) Recent clinical and molecular insights into emerging artemisinin resistance in Plasmodium falciparum. Curr Opin Infect Dis 24: 570–577 doi:10.1097/QCO.0b013e32834cd3ed.
[16]
Golenser J, Waknine JH, Krugliak M, Hunt NH, Grau GE (2006) Current perspectives on the mechanism of action of artemisinins. Int J Parasitol 36: 1427–1441 doi:10.1016/j.ijpara.2006.07.011.
[17]
Bickerton GR, Paolini GV, Besnard J, Muresan S, Hopkins AL (2012) Quantifying the chemical beauty of drugs. Nat Chem 4: 90–98 doi:10.1038/nchem.1243.
[18]
Kararli TT (1989) Gastrointestinal absorption of drugs. Crit Rev Ther Drug 6: 39–86.
[19]
Diamond JM, Wright EM (1969) Molecular forces governing non-electrolyte permeation through cell membranes. P R Soc Lond B-Conta 171: 273–316.
[20]
Wils P, Warnery A, Phung-Ba V, Legrain S, Scherman D (1994) High lipophilicity decreases drug transport across intestinal epithelial cells. J Pharmacol Exp Ther 269: 654–658.
[21]
Abraham MH, Chadha HS, Mitchell RC (1994) Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. J Pharm Sci 83: 1257–1268 doi:10.1002/jps.2600830915.
[22]
Hartwig CL, Rosenthal AS, D'Angelo J, Griffin CE, Posner GH, et al. (2009) Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent. Biochem Pharmacol 77: 322–336 doi:10.1016/j.bcp.2008.10.015.
[23]
del Pilar Crespo M, Avery TD, Hanssen E, Fox E, Robinson TV, et al. (2008) Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology. Antimicrob Agents Ch 52: 98–109 doi:10.1128/AAC.00609-07.
[24]
Alexander MD, Burkart MD, Leonard MS, Portonovo P, Liang B, et al. (2006) A central strategy for converting natural products into fluorescent probes. Chembiochem 7: 409–416 doi:10.1002/cbic.200500466.
[25]
Mackey ZB, Baca AM, Mallari JP, Apsel B, Shelat A, et al. (2006) Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei. Chem Biol Drug Des 67: 355–363 doi:10.1111/j.1747-0285.2006.00389.x.
[26]
Zhang J-H, Chung TDY, Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67–73 doi:10.1177/108705719900400206.
[27]
Still WC, Kahn M, Mitra A (1978) Rapid chromatographic technique for preparative separations with moderate resolution. J Org Chem 43: 2923–2925 doi:10.1021/jo00408a041.
